Nuzenio

Allsci Acurx

Allsci Acurx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 3 latest news signals 1 publisher sources 100/100 entity strength

Timeline

Mon, 10 Aug 2026 16:50:24 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSci
Mon, 10 Aug 2026 14:22:58 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSci
Mon, 10 Aug 2026 13:57:16 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSci

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Allsci Acurx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.